(Q38160246)

30 August 2017

title

Delivery of RNAi therapeutics: work in progress (English)

1 reference

30 August 2017

Andrew D Miller

1

1 reference

30 August 2017

publication date

1 November 2013

1 reference

Expert Review of Medical Devices

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

781-811

1 reference

RNA interference as an anticancer therapy: a patent perspective

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The silent revolution: RNA interference as basic biology, research tool, and therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Knocking down disease with siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The silent treatment: siRNAs as small molecule drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Therapeutic applications of RNAi for silencing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Biology and applications of small nucleolar RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An introduction to small non-coding RNAs: miRNA and snoRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

SNOntology: Myriads of novel snoRNAs or just a mirage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

From snoRNA to miRNA: Dual function regulatory non-coding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

RNA interference: from basic research to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Nonviral delivery of synthetic siRNAs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Nonviral methods for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipid-based systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Stability study of unmodified siRNA and relevance to clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic delivery and quantification of unformulated interfering RNAs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Intravenous, non-viral RNAi gene therapy of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

shRNA and siRNA delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Delivery of small-interfering RNA (siRNA) to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Oral delivery of siRNA and antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Stability and delivery of RNA via the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Application of siRNA against SARS in the rhesus macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Liposomal nanomedicines: an emerging field

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

21 January 2018

Liposomal nanomedicines

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipid-based nanoparticles for nucleic acid delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Extracellular targeting of synthetic therapeutic nucleic acid formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipidic systems for in vivo siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

siRNA conjugate delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Bioreducible polymers for efficient gene and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Strategies for targeted nonviral delivery of siRNAs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic delivery and pre-clinical evaluation of nanoparticles containing antisense oligonucleotides and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Central delivery of Dicer-substrate siRNA: a direct application for pain research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeted delivery of small interfering RNA: approaching effective cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Stabilized plasmid-lipid particles: construction and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Quantitative evaluation of siRNA delivery in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Development of lipidoid-siRNA formulations for systemic delivery to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipid-like materials for low-dose, in vivo gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Surface-modified LPD nanoparticles for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Nanoparticles evading the reticuloendothelial system: role of the supported bilayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic siRNA delivery to leukocyte-implicated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Microenvironmental regulation of biomacromolecular therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Intracellular trafficking of nonviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Real-time measurement of endosomal acidification by a novel genetically encoded biosensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Examination of the effect of increasing the number of intra-disulfide amino functional groups on the performance of small molecule cyclic polyamine disulfide vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Effect of surface charge and ligand organization on the specific cell-uptake of uPAR-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The role of nonbilayer lipid structures in the fusion of human erythrocytes induced by lipid fusogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The design of cationic lipids for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

In vivo delivery of RNAi with lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Cellular and molecular barriers to gene transfer by a cationic lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Enzyme-triggered PEGylated pDNA-nanoparticles for controlled release of pDNA in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Bioresponsive small molecule polyamines as noncytotoxic alternative to polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Synthesis and application of integrin targeting lipopeptides in targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Aptamer mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

dsCheck: highly sensitive off-target search software for double-stranded RNA-mediated RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Approaches for chemically synthesized siRNA and vector-mediated RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Chemically modified siRNA: tools and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Targeting of microRNAs for therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Overcoming the innate immune response to small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

siRNA and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Small non-coding RNAs as magic bullets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Phosphorothioate-stimulated uptake of short interfering RNA by human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Silencing of microRNA families by seed-targeting tiny LNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Pulmonary delivery of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Non-viral siRNA delivery to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Blood-brain barrier transport of non-viral gene and RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Assessing siRNA pharmacodynamics in a luciferase-expressing mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Quantum dots to monitor RNAi delivery and improve gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

In vivo imaging of siRNA delivery and silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Phosphorothioate-stimulated cellular uptake of siRNA: a cell culture model for mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Phosphorothioate-stimulated uptake of siRNA by mammalian cells: a novel route for delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Barriers to successful delivery of short interfering RNA after systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Breaking the bonds: non-viral vectors become chemically dynamic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Navigare necessere est. Improved navigation would help to solve two crucial problems in modern drug therapy: toxicity and precise delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Cleavage of the siRNA passenger strand during RISC assembly in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.2013.855471

10.1586/17434440.2013.855471

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference